Metabolically Armed BCMA CAR-T cells.: Clinical Trials

1 trial of Metabolically Armed BCMA CAR-T cells., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow Metabolically Armed BCMA CAR-T cells.: new trials by email Literature Review of Metabolically Armed BCMA CAR-T cells. trials Research Report on Metabolically Armed BCMA CAR-T cells.

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Metabolically Armed BCMA CAR-T cells. - Multiple Myeloma (MM), Plasma Cell Leukemia (PCL)
Early Phase 1RecruitingAnhui Provincial Hospital362025-06-232025-07-25

Conditions studied

Immunoglobulin Light-chain Amyloidosis (1)  ·  Leukemia, Plasma Cell (1)  ·  Multiple Myeloma (1)

Sponsors

Anhui Provincial Hospital (1)

Countries

China (1)